GrantExec

Catalyze: Product Definition Device Prototype Design and Testing, Diagnostic Disease Target Identification and Assay Development, and Research Tool Development (R61/R33 - Clinical Trial Not Allowed)

The Catalyze Product Definition Funding Opportunity Announcement (FOA) offers early-stage financial support for the development and testing of medical device prototypes, identification of disease targets for diagnostics, and creation of research tools to treat heart, lung, blood, and sleep (HLBS) disorders, with the goal of advancing these projects to a stage where they can qualify for the NHLBI Catalyze Preclinical program or secure further development funding from other sources.

$250,000
Closed
Nationwide
Key Dates

Next Deadline

October 21, 2024

Letter of Intent

Application Opens

January 24, 2022

Application Closes

November 21, 2024

Contact Information

Grantor

NIH OER Webmaster

Subscribe to view contact details

Newsletter Required
Categories
Health